Welcome to the Division of Pulmonary, Allergy & Critical Care Medicine
The Division of Pulmonary, Allergy, and Critical Care Medicine (PACCM) is comprised of a team of outstanding clinicians, scientists, and scholars dedicated to improving the lives of patients with serious lung and allergic diseases and those who are critically ill. Read more
PACCM Diversity Statement:
Stanford PACCM supports the Black Lives Matter movement and is committed to fighting racial injustice in our community and country. We recognize institutionalized racism as a public health crisis, and stand alongside all who are calling for sweeping and transformative changes. Our division stands firm in supporting diversity in the many forms it takes and is dedicated to promoting the health of our patients and the communities we serve. We additionally recognize the disparities that persist within the halls of academic medicine and will work hard to enable every member of our faculty, fellowship, residency, and student body to find success. Our division stands united in taking the actions needed to build a more diverse and inclusive environment for our patients, trainees, and faculty.
PACCM is one division of a larger Department of Medicine (DOM). The Stanford DOM is fully committed to supporting diversity and inclusion.
About our Fellowship Program
Welcome to the Stanford Pulmonary, Allergy and Critical Care Medicine Fellowship. We offer a 3-year ACGME accredited fellowship designed to provide outstanding clinical and research training in an intellectually vibrant and highly supportive learning environment. Our fellowship’s four distinct tracks are structured to offer trainees experiences that align with their unique career goals. We also offer an additional 4th year of subspecialty training in Lung Transplantation, Pulmonary Hypertension and Sleep Medicine which fellows can apply for in their third year.
All fellows receive 18-20 months of clinical training in Pulmonary & Critical Care Medicine with core rotations at Stanford University Hospital, the Santa Clara Valley Medical Center, and the Palo Alto VA Health Care System. By rotating at these hospitals with distinct patient populations, fellows are exposed to a wide breadth of disease states and pathology. Our elective courses provide the opportunity for the additional in-depth study of specific areas of interest. Our fellows are also provided ample time to explore outstanding research opportunities at Stanford. Thank you for your interest in our fellowship program and for exploring our website. Please don't hesitate to contact us for further information. We are currently recruiting fellows for the class of 2020, as part of the NRMP match.
Events and Announcements
September 1, 2022
We are happy to announce a major publication and new leadership position for Dr. Angela Rogers. She has authored a study evaluating the association of a biomarker with clinical outcomes in COVID-19 and has been named the Director of the new Critical Care Medicine Research Program in the Department of Medicine at Stanford.
The paper, published in the Annals of Internal Medicine (Impact Factor: 52), evaluated 2540 subjects at 114 centers in 10 countries. The objective of the study was to determine whether levels of plasma SARS-CoV-2 nucleocapsid (N) antigen can predict short-term clinical outcomes and identify clinical and viral factors associated with plasma antigen levels in hospitalized patients with SARS-CoV-2. The paper concludes that elevated plasma antigen is highly associated with both severity of pulmonary illness and clinically important patient outcomes. While the simplified concept of COVID pathogenesis suggests it’s the virus that matters early in outpatients and in hospitalized patients what matters is inflammation, this data supports an important role of ongoing viral replication in a subset of hospitalized patients. This subset could be enrolled in future anti-viral clinical trials in COVID-19. Understanding the biologic heterogeneity of critical illness has been the focus of her entire research career.
This publication arrives at a timely moment for Dr. Rogers. As many of you know, Angela has had important leadership roles in the Division, the Department, the hospital, and at the national level. She is the Associate Program Director for both the PCCM Fellowship and Internal Medicine Residency. She is a clinically active MICU attending and was instrumental in helping lead Stanford's response to the pandemic, heading a Stanford task force that developed guidelines for the care of COVID-19 patients. For her pivotal work and clinical excellence, she was named SHC's Physician of the Year in 2021. More recently, Dr. Rogers was elected Chair of the Allergy, Immunology, and Inflammation for the American Thoracic Society (2022-2023). For years, s
helping to direct and lead collaborative Stanford-based and extramural CCM grant proposals. This leadership position dovetails with the DOM's major effort in 2022-23 to build team science among our medicine divisions. She will also continue in this role to work with outstanding colleagues across other departments in our multidisciplinary ICU. Please congratulate Angela for both her impactful paper and this leadership role in this exciting new research program when you see her.
August 29, 2022
A big congratulations to Dr. Anna Arroyo, the Clinical Chief of Allergy at Stanford and Medical Director, Allergy, Asthma, & Immunodeficiency Clinic for winning the 2022 Department of Medicine Chair Diversity Investigator Award.
Her proposal addresses the social determinants of health and asthma outcomes among the Asian-American population. As the recipient of this award, Anna will present her research findings to the Stanford community and to wider audiences including a presentation of her preliminary findings/interim data at a Medicine Grand Rounds in the fall of 2023. Beyond the award period, as a Department of Medicine Chair Diversity Investigator Fellow, she will be part of the Diversity & Inclusion Research network, a special circle of distinguished researchers making significant contributions to health disparities and health outcomes.
August 24, 2022
We are delighted to announce that Dr. Joon Chang will be joining the Interventional Pulmonology Program in September 2022. Dr. Chang recently completed his IP training at the Hospital of the University of Pennsylvania, one of the oldest and most preeminent programs in the country. He will be a key member of the program which is thriving under the direction of Dr. Harmeet Bedi; he will work alongside Drs. Brian Shaller, Meghan Ramsey, Arthur, and our wonderful IP Staff.
He completed his undergraduate studies at Johns Hopkins with a degree in Molecular and Cellular Biology and a music minor followed by medical school at UCLA while also serving as the music coordinator of the Acapella group, the GeffeNotes. He went to NYU for internal medicine residency followed by PCCM training at Stanford. He looks forward to continuing clinical research which focuses on airway sampling in infection, pleural disease, and DEI issues in PCCM.
Stanford has gained national prominence in the IP program which Joon will help build further with cone beam CT navigation and robotic bronchoscopy. Our ability to have access to these state-of-the-art technologies will facilitate top patient care. The partnership with Dr. Sam Wald (VP of Perioperative and Interventional platforms) and support from the leaders of Cancer and Transplant Destination Services Lines,\ have been tremendously supportive in this process. Joon will also be a key mentor with our new IP fellowship, assisting East Bay efforts, including critical care medicine at ValleyCare Hospital.
August 17, 2022
We are very pleased to welcome Dr. Deborah Levine, Professor of Medicine at the University of Texas at San Antonio, and Dr. Amit Banga, an Associate Professor of Medicine at the University of Texas Southwestern to our Stanford PACCM Division Faculty.
Deb has an international reputation in the fields of lung transplantation and pulmonary hypertension. Dr. Levine has been instrumental in developing international guidelines for defining, diagnosing, and managing antibody-mediated rejection after lung transplantation. She also studies lung allograft monitoring using novel biomarkers such as donor-derived cell-free DNA, a technique pioneered at Stanford. Additionally, she will be the Director of Outreach for the Lung Transplant Program. Dr. Levine looks forward to developing a strong relationship with our pulmonary hypertension program and The Wall Center. She is an outstanding educator
Amit has an international reputation in the field of lung transplantation. He has been recognized as an outstanding clinician and clinical researcher. Dr. Banga's scholarship focuses on donor optimization and utilization for lung transplants. In addition, he will resume his study of post-lung transplant complications and outcomes. In collaboration with surgical medical directors, Dr. Banga will assist with the development of an advanced lung rescue service. The primary focus will be on the expansion of the VV-ECMO service for lung transplantation. He will also assist with the lung transplantation program’s current efforts to grow outreach clinics in underserved areas of California, Nevada, and Oregon.
As many of you know, the lung transplant program has been exceptionally busy - our attendings have been working their fingers to the bone! The welcome addition of such experienced clinician-scholars will greatly contribute to the strong transplant culture which has been historically strong at Stanford for over 50 years after Norm Shumway performed the first adult human-to-human heart transplant in the United States on January 6, 1968. Later, Stanford cardiothoracic surgeon Dr. Bruce Reitz performed the world’s first successful heart-lung transplant on March 9, 1981,
Our lung transplant program is doing well and is growing. Led by Drs. Gundeep Dhillon (Medical Director) and J.W. MacArthur (Surgical Director), we have an excellent partnership with our CV Surgical colleagues. Our most recent statistics show that we have the highest observed graft and patient survival outcomes in California and 4th in the nation among other adult lung transplant programs. Our heart-lung transplant program continues to transplant the highest number of heart-lung transplants in the U.S. (with good outcomes). We greatly appreciate this partnership as well as those of our critical care medicine teams who help care for these patients.
Please welcome Deb and Amit when you see them!
August 16, 2022
A big congratulations to Dr. Vinicio de Jesus Perez for a $3.5M award funding the renewal of his R01 grant evaluating the role that specialized blood vessel cells, known as 'pericytes', in pulmonary arterial hypertension (PAH).
Vinicio's team will also study how pericytes in the heart contribute to right ventricular adaptation in response to PAH. This multi-disciplinary project involves colleagues from Stanford and other institutions in the US, Canada, and Europe. Their goal is to use this information to guide therapeutic interventions for this frequently lethal disease.
Please congratulate Vinicio and his team when you see him!
August 8, 2022
The PACCM division is happy to announce that our group was just awarded one of eight NIH Lung Transplant Consortium Center grants in the country; this award will provide five years of funding, with possible renewal. The Stanford group with collaborators will study the impaired vaccination responses of lung transplant recipients. Understanding the deficits of vaccine responses in immunocompromised patients will foster the development of improved vaccine design, adjuvants, and administration protocols. Our Clinical Center status will allow us to participate in one of the most important NIH initiatives for lung transplant research in decades. This award includes a base $2.13M fund to help support basic studies of our Center with our two partner sites at Inova-Fairfax in Maryland and Houston-Methodist in Texas with significantly more funding opportunities anticipated as pilot grants through the consortium are solicited.
Each of the eight Clinical Centers has their own theme and will participate in a national centralized biorepository and a Data Coordination Center. A unique feature of the consortium is the promotion of frontline clinicians and surgeons as members of a national steering committee. Here, Dr. Gundeep Dhillon (Medical Director of the Lung Transplant Program) and Dr. J.W. MacArthur (Surgical Director) will be the Voting Members of the National Steering Committee representing Stanford/Inova/Houston and will help shape the future of lung transplant research in the years ahead. We are thrilled to partner with Professor Bali Pulendran, the Stanford investigator who developed the field of System Vaccinology. Bali will be giving the inaugural Pulmonary Grand Rounds this year on September 9th, 2022.
Other big acknowledgments: our site PIs Drs. Steve Nathan/Shambhu Aryal (Inova-Fairfax) and Howard Huang (Houston-Methodist), Holden Maecker, Stanford Human Immune Monitoring Center, Hannah Valantine who is supporting team science at Stanford, and finally to our own Amy Tian who was central to the writing and organization of this grant application.
This will be a great opportunity for Stanford investigators to collaborate across medical and surgical disciplines, to submit new pilot grants and to gain access to a national network of highly-phenotyped tissue for science that benefits the lives of transplant patients.
August 1, 2022
A big shout out to Dr. Andrea Jonas for publishing a timely review in the BMJ (British Medical Journal) on vaping. The BMJ is one of the most widely read general medical journals in the world (Impact Factor: 93.33).
And the full-text pdf link:
July 26, 2022
The U.S. News and World Report rankings were released, and pulmonology and lung surgery continue to rise in the rankings, going from #12 to #11 this year.
We want to acknowledge the phenomenal job that you and our Stanford colleagues in related disciplines are doing.
Our colleagues in Pediatric Pulmonology & Lung Surgery continue to perform as one of the top-ranked groups in the country (#5).
Congratulations to all the fellows, faculty and staff who have worked together to forge such great divisions in PACCM and Thoracic Surgery!
Stanford Health Care ranked #10 (up from #12), as well, so another banner year for SHC.
Here's a list of the ranked pulmonology and lung surgery hospitals for 2022-2023:
#1. Mayo Clinic
#2. National Jewish Health, Denver-University of Colorado
#3. Cedars-Sinai Medical Center
#4. NYU Langone
#6. Cleveland Clinic
#7. Johns Hopkins
#10. UC San Diego
#11. New York-Presbytarian-Columbia Cornell
#14. North Shore
#14. Mayo Clinic-Phoenix
#16. Mass General
#17. Mount Sinai
#18. Houston Methodist
#21. UT Southwestern
#22. Memorial Sloan Kettering
#24. Brigham and Women's
#25. Wash U
#27. UC Davis
#28. Northwestern - Lake Forest
#34. Lenox Hill
#35. Ohio State
#36. John Muir Health - Walnut Creek
#37. Mayo Clinic - Jacksonville
#38. University of Chicago
#38. MD Anderson
#40. Advocate Lutheran
#41. Loma Linda
#41. Long Island Jewish
#43. Oregon Health Sciences (OHSU)
#44. CentraCare-St. Cloud
#47. Thomas Jefferson
#48. University of Florida - Gainesville
#49. Tampa General
July 22, 2022
It is a distinct pleasure to announce that Dr. Raquel Lynn will be joining our PACCM Division as a Clinical Assistant Professor of Medicine. Following her PCCM fellowship, Raquel was most recently the eBay Fellow in Pulmonary Vascular Diseases. Raquel will be an active member of our adult pulmonary hypertension (PH) program, participating in on the clinical inpatient service, in the cardiac catheterization laboratory as a procedural attending, and expanding the scope of the PH program to the Stanford Health Care-ValleyCare campus. She will help Dr. Yon Sung co-direct the newly established Stanford chronic thromboembolic pulmonary hypertension (CTEPH)/pulmonary thromboendarterectomy (PTE) program that will provide a surgical and interventional platform for patients with chronic thromboembolic disease.
Please join us in welcoming Raquel to the PACCM family!
May 20, 2022
The PACCM division wants to share the good news that two of our faculty were elected to leadership roles in ATS: Vinicio de Jesus Perez was elected chair of the Pulmonary Hypertension Assembly and Angela Rogers was elected chair of Allergy, Immunology, and Inflammation. In addition to leading their assemblies, in these roles, both will serve as members of the ATS board of directors for three years. It's delighful to see Stanford faculty helping lead our society. Congrats to Angela and Vinicio!
May 12, 2022
We are excited to announce that Drs. Andrew Moore, PCCM fellow in the PACCM division and Dr. Pablo Sanchez, cardiology fellow will be the next physician-scientists to join the T-32 funded, Stanford Pulmonary Biology Training Program.
With the addition of Drs. Sanchez and Moore, we continue to build our community of invested, intellectually-engaged pulmonary physician-scientists. Dr. Moore will be studying multi-omic endotyping of ARDS and sepsis working under the mentorship of Dr. Purvesh Khatri and Dr. Angela Rogers. Dr. Sanchez will be examining RV dysfunction in ARDS, training with Dr. Angela Rogers and Drs. Euan Ashley and Francois Haddad. We are delighted to welcome these new scholars and their mentors into the Stanford Pulmonary Biology Training community!
March 14, 2022
We are excited to announce that Dr. Brian Shaller has been voted the 2021 PACCM Teaching Award Winner - a big achievement considering the large faculty size of our division and the considerable number of outstanding educators. Brian will be awarded $5,000 and honored with other Divisional winners in the DOM. Brian is consistently viewed as an educator and clinician par excellence. Trainees are universally impressed by his technical skills, deep knowledge base, and humble bearing.
Brian is originally from NYC and went to medical school at Albert Einstein School of Medicine. He completed both his medicine residency and PCCM fellowship at Stanford. He pursued interventional pulmonology training at the Cleveland Clinics program and returned as faculty to Stanford in August of 2020. Brian was instrumental in initiating our newly inaugurated Interventional Pulmonology Fellowship Program. We are super proud to have him in our ranks. A big congratulations for this well-deserved honor, Brian!
March 10, 2022
We are very excited to announce that two of our PCCM fellows, Solmaz Afshar and Landy Luna Diaz, have been accepted to the ACGME Advancing Innovation in Residency Education (AIRE) - Sleep Medicine program, sponsored by the American Academy of Sleep Medicine (AASM). This pilot initiative was created by ACGME to catalyze innovations in graduate medical education and improve barriers to sleep medicine training. We are thrilled to be able to provide this rare opportunity to our fellows with a strong interest in pursuing sleep medicine as part of their career trajectory.
In close collaboration with Stanford's world-renowned Division of Sleep Medicine, Solmaz and Landy will complete comprehensive sleep medicine fellowship training along with special focus on pulmonary and sleep disorders within three years of PCCM fellowship. At completion of training both fellows will be eligible for sleep medicine board certification. Solmaz and Landy will be mentored and supervised by our own faculty programmatic leads Michelle Cao and Gaurav Singh, who are board certified in sleep medicine. We view this opportunity as a testament to the Division's commitment towards educational opportunities and supporting personalized career pathways for our fellows. We are grateful and proud of Michelle and Gaurav for organizing this new initiative for Stanford. Please congratulate Solmaz and Landy, our inaugural fellows, when you have the opportunity.
March 10, 2022
A big congratulations to Dr. Vinicio de Jesus Perez and his research team for receiving a $3M NIH R01 grant evaluating the pathogenesis of pulmonary arterial hypertension (PAH). In their original R01, his team confirmed a key role for the Wnt7a/ROR2 signaling pathway in lung angiogenesis and how the loss of this mechanism is a feature of PAH vascular pathology.
The renewal grant will focus on elucidating the transcriptional and epigenetic mechanisms governing the behavior of diseased endothelial cells with implications for how the right ventricle adapts in this lethal condition. Excellent news and great work, Vinicio and team!
February 11, 2022
It is the PACCM division’s great pleasure to announce that Adam Andruska has been selected as a 2022 Parker B. Francis Fellow for his research under the mentorship of Edda Spiekerkoetter. Adam will be continuing his investigations into the pathogenesis of pulmonary hypertension in Edda’s lab and co-mentored by Maya Kumar.
The PBF is a prestigious honor and award for which Adam is incredibly deserving, and is a testament to his perseverence over the years. We’re very proud of and happy for him.
February 9, 2022
Please consider attending this year's CTS Annual Educational Conference. This is one of the best programs that we have seen for this meeting. With subjects ranging from post-ICU care, modes of ventilation and proning, hands-on sessions with ventilators/oxygen delivery devices/neural triggering for OSA, lung cancer, sleep disorders, climate change/environmental pollution, pandemic career development/wellness, and women in PCCM/Sleep medicine, this program offers something for everyone - and will occur in the lovely Portola Hotel and Spa in Monterey.
We need to call out a few of Stanford's faculty. Our group is becoming increasingly prominent in the California Thoracic Society. First a big congratulations to our very own Drs. Kristina Kudelko and Gaurav Singh who are the Conference Co-Chairs - amazing job, you two. We also have to celebrate Dr. Michelle Cao, the current CTS President. We look forward to attending the conference in person this year.
January 20, 2022
"Newsweek has created international rankings for specialized hospitals and this year added Pulmonology as a category. Stanford did well for this initial outing coming in at number 7!
For the full list of 125 ranked programs, here is the link https://www.newsweek.com/worlds-best-specialized-hospitals-2022/pulmonology"
See our Grand Rounds, Core Lectures, Conferences, and more.
IASLC WCLC (World Conference on Lung Cancer): August 6-9, 2022: Vienna
CHEST Annual Meeting: October 16-19, 2022: Nashville, TN
North American Cystic Fibrosis (NACFC) Conference: November 3-5, 2022: Philadelphia, PA
American Academy of Allergy, Asthma & Immunology (AAAAI) Annual Meeting: February 24-27, 2023: San Antonio, TX
ISHLT Annual Meeting: April 19-22, 2023: Denver, CO
American Thoracic Society (ATS): May 19-24, 2023: Washington, DC